首页> 外文期刊>Current pharmaceutical analysis. >Preparation and Characterization of Binary and Ternary Complexes of Dihydroartremisinin with Hydroxypropyl-beta-cyclodextrin, Palmitic acid and Polyvinylpyrrolidone K30
【24h】

Preparation and Characterization of Binary and Ternary Complexes of Dihydroartremisinin with Hydroxypropyl-beta-cyclodextrin, Palmitic acid and Polyvinylpyrrolidone K30

机译:二氢青蒿素与羟丙基-β-环糊精,棕榈酸和聚乙烯吡咯烷酮K30的二元和三元配合物的制备和表征

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The objective of current study was to improve solubility of poorly water-soluble antimalarial drug named dihydroartemisinin via the development of binary complexes of DHA with hydroxypropyl-beta-cyclodextrin(HP-beta-CD), ternary complexes of DHA-(HP-beta-CD)-Palmitic acid and DHA-(HP-beta-CD)-PVPK30 (PolyvinylpyrrolidoneK30). These complexes were prepared in various drug to excipients ratios by physical mixing and freeze dried (FD) methods. Characterization was performed by powder X-ray diffraction patterns, Scanning Electron Microscopy (SEM), Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy (ATR-FTIR), solubility test, and dissolution studies. Aqueous solubility of binary complexes of DHA increased up to 27 folds, 36 folds in DHA-(HP-beta-CD)-palmitic acid and 216 folds in DHA-(HP-beta-CD)-PVPK30 ternary complexes. The highest dissolution rate was observed to be 60 times improved for ternary FDCs of DHA-(HP-beta-CD)-PVPK30 as compared to pure DHA. The crystallinity of DHA was decreased in physical mixtures while XRD patterns of freeze dried complexes (FDCs) showed least number of peaks having low intensity along with more displaced angles. The SEM images of PMs showed cavities and FDCs exhibited reduced particle size in binary and ternary systems. ATR-FTIR spectra of binary and ternary complexes revealed bonding interactions among DHA, HP-beta-CD, palmitic acid and PVPK30. It can be concluded that binary complex formation of DHA with hydroxypropyl-beta-cyclodextrin(HP-beta-CD) and ternary complexes of DHA-(HP-beta-CD)-Palmitic acid and DHA( HP-beta-CD)-polyvinylpyrrolidone K30 is a suitable approach to enhance solubility of DHA.
机译:本研究的目的是通过开发DHA与羟丙基-β-环糊精(HP-β-CD)的二元复合物,DHA-(HP-β-三元复合物)来改善水溶性差的抗疟疾药物二氢青蒿素的溶解性CD)-棕榈酸和DHA-(HP-β-CD)-PVPK30(聚乙烯吡咯烷酮K30)。通过物理混合和冷冻干燥(FD)方法以各种药物与赋形剂的比例制备这些复合物。通过粉末X射线衍射图,扫描电子显微镜(SEM),衰减全反射傅立叶变换红外光谱(ATR-FTIR),溶解度测试和溶解度研究进行表征。 DHA二元复合物的水溶性增加了27倍,在DHA-(HP-β-CD)-棕榈酸中增加了36倍,在DHA-(HP-β-CD)-PVPK30三元复合物中增加了216倍。与纯DHA相比,DHA-(HP-β-CD)-PVPK30的三元FDC的最高溶解速率提高了60倍。在物理混合物中,DHA的结晶度降低,而冷冻干燥的复合物(FDC)的XRD图谱显示,具有最低强度的峰数量最少,且位移角更大。在二元和三元系统中,PM的SEM图像显示出空腔,而FDC的粒径减小。二元和三元复合物的ATR-FTIR光谱揭示了DHA,HP-β-CD,棕榈酸和PVPK30之间的键合相互作用。可以得出结论,DHA与羟丙基-β-环糊精(HP-β-CD)形成二元复合物,DHA-(HP-β-CD)-棕榈酸与DHA(HP-β-CD)-聚乙烯吡咯烷酮三元复合物形成K30是增强DHA溶解度的合适方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号